Alnylam Pharmaceuticals
Roumen Radinov holds significant expertise in the field of process chemistry and organic chemistry, currently serving as the Director of Process Chemistry at Alnylam Pharmaceuticals. Prior experience includes various senior roles at Roche Pharmaceuticals, where contributions as a Senior Principal Scientist, Research Leader, and Principal Scientist were made. Roumen Radinov’s educational background includes a Postdoctoral Research Associate degree in Organic Chemistry from Stanford University (1995 - 1997) and ongoing studies at Duke University in the same field.
This person is not in any teams
Alnylam Pharmaceuticals
31 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.